Amrutanjan Health Care Stock Revenue
| AMRUTANJAN | 712.45 9.60 1.37% |
Amrutanjan Health Care fundamentals help investors to digest information that contributes to Amrutanjan Health's financial success or failures. It also enables traders to predict the movement of Amrutanjan Stock. The fundamental analysis module provides a way to measure Amrutanjan Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amrutanjan Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 4.2 B | 2.3 B |
Amrutanjan | Revenue |
Amrutanjan Health Care Company Revenue Analysis
Amrutanjan Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Amrutanjan Health Revenue | 4.21 B |
Most of Amrutanjan Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amrutanjan Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Amrutanjan Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Amrutanjan Health Care reported 4.21 B of revenue. This is 44.77% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all India stocks is 55.35% higher than that of the company.
Amrutanjan Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amrutanjan Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amrutanjan Health could also be used in its relative valuation, which is a method of valuing Amrutanjan Health by comparing valuation metrics of similar companies.Amrutanjan Health is currently under evaluation in revenue category among its peers.
Amrutanjan Fundamentals
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0785 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 17.9 B | ||||
| Shares Outstanding | 28.9 M | ||||
| Shares Owned By Insiders | 59.00 % | ||||
| Shares Owned By Institutions | 10.22 % | ||||
| Price To Book | 6.79 X | ||||
| Price To Sales | 4.76 X | ||||
| Revenue | 4.21 B | ||||
| Gross Profit | 1.92 B | ||||
| EBITDA | 681.6 M | ||||
| Net Income | 449.73 M | ||||
| Cash And Equivalents | 654.13 M | ||||
| Total Debt | 17.28 M | ||||
| Book Value Per Share | 99.79 X | ||||
| Cash Flow From Operations | 279.11 M | ||||
| Earnings Per Share | 16.45 X | ||||
| Number Of Employees | 634 | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 20.31 B | ||||
| Total Asset | 3.67 B | ||||
| Retained Earnings | 2.36 B | ||||
| Working Capital | 2.26 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 3.67 B |
About Amrutanjan Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amrutanjan Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amrutanjan Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amrutanjan Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amrutanjan Stock
Amrutanjan Health financial ratios help investors to determine whether Amrutanjan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amrutanjan with respect to the benefits of owning Amrutanjan Health security.